Governance Celltrion, Inc.

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06/09/2024			5-day change	1st Jan Change
191,200.00 ^KRW	+1.70%		-5.81%	-5.11%

08-29	Celltrion Usa Partners with Express Scripts and Cigna Healthcare to Expand Access to Zymfentra® (Infliximab-Dyyb), the First and Only Fda-Approved Subcutaneous Infliximab on Their Medical Benefit Formulary	CI
08-26	European Commission Approves Celltrion's SteQeyma (CT-P43) A Biosimilar to Stelara (ustekinumab), for the Treatment of Multiple Chronic Inflammatory Diseases	CI

Executive Committee: Celltrion, Inc.

Manager

Positions heldSince

Wu-Sung Ki

62 year

Chief Executive Officer

19/03/2015

Sung-Han Lee

42 year

Compliance Officer	-
General Counsel	-

Ho-Seop Lee

49 year

Director of Finance/CFO

Composition of the Board of Directors: Celltrion, Inc.

Director

CommitteesSince

Jung-Jin Seo

66 year

Nominating Committee

Joseph Lee

66 year

Audit Committee Chair

16/07/2008

Gyun-Seok Cho

65 year

Audit Committee

19/03/2009

Dong-Il Kim

66 year

Audit Committee

16/07/2008

Jong-Seok Lee

72 year

Audit Committee

07/12/2014

Young-Hye Ko

69 year

Director/Board Member
Independent Dir/Board Member

Wu-Sung Ki

62 year

Director/Board Member

23/04/2007

Byung-Hoon Jeon

66 year

Director/Board Member	26/03/2014
Independent Dir/Board Member	26/03/2014

Geun-Young Kim

64 year

Director/Board Member
Independent Dir/Board Member

Dae-Hyeon Yoo

65 year

Director/Board Member
Independent Dir/Board Member

Soon-Woo Lee

73 year

Director/Board Member
Independent Dir/Board Member

Jae-Sik Lee

66 year

Director/Board Member
Independent Dir/Board Member

Min-Cheol Shin

61 year

Director/Board Member

Hyeok-Jae Lee

49 year

Director/Board Member

Latest Appointments: Celltrion, Inc.

Celltrion Group Creator Expected to Resume Leadership Role

07/03/23

More news

Former Officers and Directors: Celltrion, Inc.

Insider

Positions heldSinceUntil

Won-Seok Kim

Director/Board Member	-	31/03/2022
Independent Dir/Board Member	-	31/03/2022

Hong-Hee Cho

Director/Board Member	21/03/2013	-
Independent Dir/Board Member	21/03/2013	-

Zheru Zhang

Chief Tech/Sci/R&D Officer

29/02/2008

30/09/2012

Brian Byeoung Kim

Corporate Officer/Principal

31/05/2011

29/04/2012

Jin-Kyu Wang

Corporate Officer/Principal

01/06/2011

29/04/2012

Daniel P. Slone

Corporate Officer/Principal

31/05/2011

John S. Kim

Corporate Officer/Principal

01/06/2011

Hans-Peter Hasler

Director/Board Member	31/05/2011	-
Independent Dir/Board Member	31/05/2011	-

Gyung-Ho Lee

Director/Board Member

16/07/2008

James Panek

Chief Executive Officer	31/12/2001	31/12/2005
Chairman	31/12/2001	31/12/2005

Hyung-Ki Kim

Director/Board Member	31/03/2005	-
Chief Executive Officer	19/03/2015	-
Corporate Officer/Principal	31/03/2005	-

Myung-Geun Oh

Chief Operating Officer	-	-
Corporate Officer/Principal	-	-

Sung-Do Park

Corporate Officer/Principal

01/06/2011

Seung-Seo Hong

Chief Tech/Sci/R&D Officer

31/05/2011

Hee-Choon Yang

Corporate Officer/Principal

31/05/2011

Elizabeth Pollitt

Corporate Officer/Principal

Alex Kudrin

Corporate Officer/Principal

Jae Chung

Founder	-	-
Corporate Officer/Principal	-	-

Yong-Jik Kim

Corporate Officer/Principal

31/05/2011

Serge S. Laveault

Corporate Officer/Principal

Dong-Gyu Ji

Corporate Officer/Principal

Jeong-Soo Suh

Corporate Officer/Principal

Gail M. Ward

Corporate Officer/Principal

Hong-Seok Cho

Corporate Officer/Principal

01/06/2011

In-Kyu Kim

Corporate Officer/Principal

31/05/2011

Yun-Sook Jang

Corporate Officer/Principal

01/06/2011

Min-Young Soh

Corporate Officer/Principal

31/05/2011

Ho-Eun Yoo

Corporate Officer/Principal

01/06/2011

Ik-Sung Ahn

Corporate Officer/Principal

01/06/2011

Kwang-Ho Kim

Corporate Officer/Principal

31/05/2011

Geun-Kyung Lee

Corporate Officer/Principal

31/05/2011

Young-Seon Kwon

Corporate Officer/Principal

01/06/2011

Bok-Jong Hyun

Corporate Officer/Principal

01/06/2011

Je-Roo Jang

Corporate Officer/Principal

01/06/2011

Seung-Heon Nam

Corporate Officer/Principal

31/05/2011

Young-Deok Gwon

Corporate Officer/Principal

Gang-Heui Cho

Corporate Officer/Principal

Jae-Hyeon Kim

Corporate Officer/Principal

01/06/2011

Age distribution of managers

Parity Men Women

Male	20
Female	0

Of which Executive Committee

Male	3
Female	0

Of which Directors

Male	14
Female	0

ESG Refinitiv

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Employees

2,391

Sector

Biotechnology & Medical Research

Calendar

10/11/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Departures of Key Persons

Hyung-Ki Kim

Chief Executive Officer

19/03/2015 -

James Panek

Chief Executive Officer

31/12/2001 31/12/2005

Governance Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

Executive Committee: Celltrion, Inc.

Composition of the Board of Directors: Celltrion, Inc.

Latest Appointments: Celltrion, Inc.

Former Officers and Directors: Celltrion, Inc.

Age distribution of managers

Parity Men Women

Environment

Governance

Controversy

Company Profile

Departures of Key Persons

Governance Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

Executive Committee: Celltrion, Inc.

Composition of the Board of Directors: Celltrion, Inc.

Latest Appointments: Celltrion, Inc.

Former Officers and Directors: Celltrion, Inc.

Age distribution of managers

Parity Men Women

Environment

Social

Governance

Controversy

Company Profile

Departures of Key Persons